Originally developed to treat people with type-2 diabetes (T2DM), these drugs have proven useful for addressing a range of other conditions, from obesity to sleep apnea
Klinic providers will conduct assessments to ensure this treatment is suitable
It goes without saying that in our culture, health and wellness are constantly at the forefront of our minds
Available from: Accessed Mar 07, 2024 Eli Lilly and Company
By analogy with semaglutide (where the STEP-4 withdrawal trial demonstrated substantial weight regain within 12 months of discontinuation), researchers should anticipate that weight regain is likely following cessation of any GLP-1 class compound, including retatrutide
For patients using FDA-approved pre-filled pens, the pen automatically delivers the correct volume for the selected milligram dose